OZYVYO
Live / Allowed — Second extension granted (statement of use) (as of 24 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 08 Jan 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 98944429
- Mark type
- Word mark
- Filed
- 08 Jan 2025
- Published for opposition
- 22 Jul 2025
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of bone, genetic, joint, metabolic, musculoskeletal, osteopathic, orthopedic, and skeletal diseases and disorders
Owner
- Ultragenyx Pharmaceutical Inc., Novato, CA, US
- Ultragenyx Pharmaceutical Inc., Novato, CA, US
Prosecution history
- 25 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Aug 2026 — SOU EXTENSION 2 GRANTED
- 24 Aug 2026 — SOU EXTENSION 2 FILED
- 24 Aug 2026 — SOU TEAS EXTENSION RECEIVED
- 05 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Mar 2026 — SOU EXTENSION 1 GRANTED
- 04 Mar 2026 — SOU EXTENSION 1 FILED
- 04 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 16 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 22 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Jul 2025 — PUBLISHED FOR OPPOSITION
- 16 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Jun 2025 — ASSIGNED TO EXAMINER
- 08 Jan 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED